The Appellate Tribunal Inland Revenue (Karachi Bench) ruled in favour of a leading pharmaceutical multinational, clarifying the scope of sales tax exemptions for therapeutic products. This landmark pharmaceutical tax exemption judgment annulled demands for sales tax, default surcharges, and penalties.
RIAA Barker Gillette Achieves Top Legal 500 Pakistan Rankings
RIAA Barker Gillette secures Band 1 Legal 500 rankings across four practice areas in the 2026 Asia Pacific guide. Multiple partners recognised as leading lawyers in Pakistan.
RIAA Advises Global Explosives Firm on Mining Sector in Pakistan
RIAA Barker Gillette has advised a global leader in commercial explosives and blasting technology on entering the mining sector in Pakistan. The firm prepared a comprehensive country report assessing the legal framework and country risks relevant to operations in the Tethyan Belt.
RIAA Secures DAAB Decision in Major Dispute on Key Indus River Project
RIAA Barker Gillette secured a binding DAAB ruling on FIDIC price adjustment mechanisms under Sub-Clause 13.7. The decision protects USD 20 million in public funds on a USD 90 million / PKR 17 billion Indus River irrigation project.
RIAA Advises on Acquisition of Novartis Pakistan by Getz Group
RIAA Barker Gillette advised International Investments II Limited, a Getz Group company, on its successful acquisition of Novartis Pharma (Pakistan) Limited. This landmark transaction marks a significant development in Pakistan's pharmaceutical sector.
The Insurance Rules 2017 – Comparison with Insurance Rules 2002 and the Securities and Exchange Commission (Insurance) Rules 2002
The Insurance Rules, 2017 (“2017 Rules”) were promulgated by the Securities and Exchange Commission of Pakistan on 9 February 2017, which repealed the Insurance Rules, 2002 (“2002 Rules”) and the Securities and Exchange Commission (Insurance) Rules, 2002 (“SEC Rules”).
